相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2
Shaopeng Yu et al.
PHYTOMEDICINE (2021)
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Xiaofei Chen et al.
ACTA PHARMACEUTICA SINICA B (2021)
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
Gan Wang et al.
CELL RESEARCH (2021)
The place for remdesivir in COVID-19 treatment
Barnaby Young et al.
LANCET INFECTIOUS DISEASES (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Guenther et al.
SCIENCE (2021)
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Fangfang Yan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
Cheng Wang et al.
GASTROENTEROLOGY (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Analysis on herbal medicines utilized for treatment of COVID-19
Lu Luo et al.
ACTA PHARMACEUTICA SINICA B (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Bioactive natural compounds against human coronaviruses: a review and perspective
Yanfang Xian et al.
ACTA PHARMACEUTICA SINICA B (2020)
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex
Erik Laurini et al.
ACS NANO (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges
Beata Turonova et al.
SCIENCE (2020)
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
Haiwei Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
Hua-Long Xiong et al.
EMERGING MICROBES & INFECTIONS (2020)
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine
Shuai Ji et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
Marion Sevajol et al.
VIRUS RESEARCH (2014)
A decade after SARS: strategies for controlling emerging coronaviruses
Rachel L. Graham et al.
NATURE REVIEWS MICROBIOLOGY (2013)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
分享论文
